Nath Bio-Genes (India) 대차 대조표 상태
재무 상태 기준 확인 4/6
Nath Bio-Genes (India) 의 총 주주 지분은 ₹6.4B 이고 총 부채는 ₹1.3B, 이는 부채 대 자기자본 비율을 19.9% 로 가져옵니다. 총자산과 총부채는 각각 ₹8.3B 및 ₹1.9B 입니다. Nath Bio-Genes (India) 의 EBIT는 ₹461.8M 이며 이자보상배율은 5.5 입니다. ₹20.8M 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
19.9%
부채 비율
₹1.27b
부채
| 이자 보상 비율 | 5.5x |
| 현금 | ₹20.77m |
| 주식 | ₹6.40b |
| 총 부채 | ₹1.88b |
| 총 자산 | ₹8.28b |
최근 재무 상태 업데이트
These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Jun 27
Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly
Aug 05We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt
Aug 27Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet
Feb 24Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?
Feb 28These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Nov 26Recent updates
Here's Why Shareholders Should Examine Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) CEO Compensation Package More Closely
Aug 11Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Solid Earnings May Rest On Weak Foundations
Jul 31Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Shares Fly 34% But Investors Aren't Buying For Growth
Jul 02These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Jun 27Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has More To Do To Multiply In Value Going Forward
Apr 05Returns On Capital At Nath Bio-Genes (India) (NSE:NATHBIOGEN) Have Hit The Brakes
Oct 24Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly
Aug 05Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has Some Way To Go To Become A Multi-Bagger
Jun 07Some Investors May Be Worried About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Feb 11We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt
Aug 27Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital Not Reflecting Well On The Business
Jun 19Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet
Feb 24Returns On Capital Signal Tricky Times Ahead For Nath Bio-Genes (India) (NSE:NATHBIOGEN)
May 27Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?
Feb 28The Trends At Nath Bio-Genes (India) (NSE:NATHBIOGEN) That You Should Know About
Feb 07Declining Stock and Decent Financials: Is The Market Wrong About Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)?
Jan 19The Nath Bio-Genes (India) (NSE:NATHBIOGEN) Share Price Is Up 149% And Shareholders Are Boasting About It
Jan 01Why Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay Matters
Dec 14
These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Nov 26Here's What To Make Of Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Nov 05Do Its Financials Have Any Role To Play In Driving Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) Stock Up Recently?
Oct 15Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Might Not Be As Mispriced As It Looks After Plunging 25%
Sep 24Many Still Looking Away From Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
Sep 08Introducing Nath Bio-Genes (India) (NSE:NATHBIOGEN), The Stock That Soared 311% In The Last Five Years
Sep 07Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Doing What It Can To Lift Shares
Aug 18Here's What We Think About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay
Jul 26재무 상태 분석
단기부채: NATHBIOGEN 의 단기 자산 ( ₹5.2B )이 단기 부채( ₹1.8B ).
장기 부채: NATHBIOGEN 의 단기 자산( ₹5.2B )이 장기 부채( ₹68.6M ).
부채 대 자본 내역 및 분석
부채 수준: NATHBIOGEN 의 순부채 대 자기자본 비율( 19.6% )은 satisfactory로 간주됩니다.
부채 감소: NATHBIOGEN 의 부채 대 자기자본 비율은 지난 5년간 12.2% 에서 19.9% 로 증가했습니다.
부채 범위: NATHBIOGEN 의 부채는 영업 현금 흐름 ( 8.8% )에 의해 잘 갚지 않음입니다.
이자 보장: NATHBIOGEN 의 부채에 대한 이자 지급은 EBIT( 5.5 x 적용 범위)로 잘 충당됩니다.